Association of Transforming Growth Factor -- β1 Functional Polymorphisms with Natural Clearance of Hepatitis C Virus

Kimura, Tomomi; Saito, Takafumi; Yoshimura, Mika; Song Yixuan; Baba, Masanori; Guijin Ji; Muramatsu, Masaaki; Kawata, Sumio
May 2006
Journal of Infectious Diseases;5/15/2006, Vol. 193 Issue 10, p1371
Academic Journal
Transforming growth factor (TGF)-β1 suppresses the proliferation and cytotoxicity of natural killer (NK) cells, which play critical roles in resolving hepatitis C virus (HCV) infection, especially during the acute phase. We examined 230 anti-HCV antibody-positive subjects for HCV RNA and the -509T/C genotype in the TGF-β1 gene promoter. The -509CC genotype and the -509C allele were significantly associated with higher HCV clearance rates (P < .01) and with lower transcriptional activity. The genetic effect remained significant even after adjustment for a history of transfusion. Low TGF-β1 producers might have less suppression of NK cells and be more likely to resolve HCV infection.


Related Articles

  • Recombination in Hepatitis C Virus: Identification of Four Novel Naturally Occurring Inter-Subtype Recombinants. Shi, Weifeng; Freitas, Ines T.; Zhu, Chaodong; Zheng, Wei; Hall, William W.; Higgins, Desmond G. // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Recombination in Hepatitis C virus (HCV) is considered to be rare. In this study, we performed a phylogenetic analysis of 1278 full-length HCV genome sequences to identify potential recombination events. Nine inter-genotype recombinants were identified, all of which have been previously...

  • Rate of Sustained Virologic Response in Relation to Baseline Hepatitis C Virus (HCV) RNA Level and Rapid Virologic Clearance in Persons with Acute HCV Infection. McGovern, Barbara H.; Nagami, Ellen H.; Birch, Christopher E.; Bowen, Melinda J.; Reyor, Laura L.; Chung, Raymond T.; Kim, Arthur Y. // Journal of Infectious Diseases;9/15/2009, Vol. 200 Issue 6, p877 

    Treatment of acute hepatitis C virus (HCV) infection leads to a sustained virologic response (SVR) in the vast majority of patients, although the clinical predictors of these favorable responses are not well understood. In chronic infection, the most potent predictor of a SVR is complete viral...

  • Nonresponder Patients with Hepatitis C Virus Genotype 2/3 Infection: A Question of Low Systemic Interferon Concentrations? Alsiö, Åsa; Christensen, Peer Brehm; Färkkilä, Martti; Langeland, Nina; Buhl, Mads Rauning; Pedersen, Court; Mørch, Kristine; Haagmans, Bart L.; Westin, Johan; Hellstrand, Kristoffer; Norkrans, Gunnar; Lagging, Martin // Clinical Infectious Diseases;2/15/2010, Vol. 50 Issue 4, pe22 

    Twelve of 303 per-protocol patients were nonresponders in a 12-week versus 24-week treatment study of hepatitis C virus (HCV) genotype 2/3 infection. The nonresponders had significantly lower interferon concentrations, as well as significantly greater mean age, body mass index, and viral load....

  • Do high lipids help clearance of hepatitis C? Ryder, Stephen // Gut;Aug2007, Vol. 56 Issue 8, p1044 

    The article discusses the importance of lipids and lipid receptors in the high rate of spontaneous clearance of hepatitis C virus (HCV). The chance of clearing HCV infection is significantly higher in patients who have high triglycerides (TG) levels. The effect of TG levels is credible, HCV is...

  • Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts.  // BMC Research Notes;2011, Vol. 4 Issue 1, p468 

    The article presents a study investigating molecular epidemiology of hepatitis C virus (HCV) infection in Cyprus within the general population and high-risk groups. The subjects of the study include additional subjects from the general population which is a group of inmates and HIV/HCV...

  • La frecuencia del genotipo 1 del virus de hepatitis C no ha variado en Venezuela. del Pilar Fortes, María; Trómpiz, Aleidy; Canónico, Yeily; Vargas-Lovelle, Berta; Machado, Irma V. // Revista Colombiana de Gastroenterología;Jul2009, Vol. 24 Issue 3, p256 

    Changes in hepatitis C virus (HCV) genotypes distribution and frequency have been reported in some countries including Venezuela. We analyze the frequency of the HCV genotypes in our country evaluating a possible distribution change at national level. Eight hundred and nine sera of patients...

  • Hepatitis C virus infection and the brain. Karin Weissenborn; Anita Tryc; Meike Heeren; Hans Worthmann; Henning Pflugrad; Georg Berding; Martin Bokemeyer; Hans Tillmann; Annemarie Goldbecker // Metabolic Brain Disease;Mar2009, Vol. 24 Issue 1, p197 

    Abstract  There is growing evidence that hepatitis C virus (HCV)-infection may affect the brain. About half of the HCV-infected patients complain of chronic fatigue irrespective of their stage of liver disease or virus replication rate. Even after successful antiviral therapy fatigue...

  • Fibrosis progression in chronic hepatitis C virus infection. McCaughan, G. W.; George, J. // Gut;Mar2004, Vol. 53 Issue 3, p318 

    Chronic hepatitis C virus infection is typically characterised by slowly progressive hepatic fibrosis. However, it is recognised that some patients do not progress while others rapidly develop significant fibrosis. Here, we review studies that have assessed factors that could influence this rate...

  • Hepatitis G virus. Reshetnyak, Vasiliy Ivanovich; Karlovich, Tatiana Igorevna; Ilchenko, Ljudmila Urievna; Mondelli, Mario U.; Reshetnyak, Vasiliy I. // World Journal of Gastroenterology;8/14/2008, Vol. 14 Issue 30, p4725 

    A number of new hepatitis viruses (G, TT, SEN) were discovered late in the past century. We review the data available in the literature and our own findings suggesting that the new hepatitis G virus (HGV), disclosed in the late 1990s, has been rather well studied. Analysis of many studies...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics